Ganciclovir Sodium

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 317965

CAS#: 107910-75-8 (sodium)

Description: Ganciclovir Sodium is an acyclovir analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.

Price and Availability


USD 250
USD 850
USD 2950

USD 450
USD 1250
USD 4850

USD 650
USD 1950

Ganciclovir Sodium, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.

Chemical Structure


Theoretical Analysis

MedKoo Cat#: 317965
Name: Ganciclovir Sodium
CAS#: 107910-75-8 (sodium)
Chemical Formula: C9H12N5NaO4
Exact Mass:
Molecular Weight: 277.21
Elemental Analysis: C, 38.99; H, 4.36; N, 25.26; Na, 8.29; O, 23.09

Related CAS #: 82410-32-0 (free)   1359968-33-4 (hydrate)   84245-13-6 (x sodium)   107910-75-8 (sodium)   352346-23-7 (potassium)    

Synonym: Ganciclovir Sodium; RS-21592 sodium; Cytovene IV; RS 21592 Sodium; BIOLF-62; BW-759 sodium; Cytovene;

IUPAC/Chemical Name: sodium;2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)purin-6-olate


InChi Code: InChI=1S/C9H13N5O4.Na/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16;/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17);/q;+1/p-1

SMILES Code: C1=NC2=C(N1COC(CO)CO)N=C(N=C2[O-])N.[Na+]

Technical Data

Solid powder

>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Soluble in DMSO, not in water

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:


1: Mulye NV, Turco SJ, Speaker TJ. Stability of ganciclovir sodium in an
infusion-pump syringe. Am J Hosp Pharm. 1994 May 15;51(10):1348-9. PubMed PMID:

2: Johnson CE, Jacobson PA, Chan E. Stability of ganciclovir sodium and amino
acids in parenteral nutrient solutions. Am J Hosp Pharm. 1994 Feb 15;51(4):503-8.
PubMed PMID: 8017417.

3: Phaypradith S, Vigneron J, Perrin A, Durney-Archeray MJ, Hoffman MA, Hoffman
M. [Stability of dilute solutions of ganciclovir sodium (Cymevan) in
polypropylene syringes and PVC perfusion bags]. J Pharm Belg. 1992
Nov-Dec;47(6):494-8. French. PubMed PMID: 1289490.

4: Parasrampuria J, Li LC, Stelmach AH, Sykes TR, Gordon GA. Stability of
ganciclovir sodium in 5% dextrose injection and in 0.9% sodium chloride injection
over 35 days. Am J Hosp Pharm. 1992 Jan;49(1):116-8. PubMed PMID: 1570851.

5: Silvestri AP, Mitrano FP, Baptista RJ, Williams DA. Stability and
compatibility of ganciclovir sodium in 5% dextrose injection over 35 days. Am J
Hosp Pharm. 1991 Dec;48(12):2641-3. PubMed PMID: 1814209.

6: Outman WR, Mitrano FP, Baptista RJ. Visual compatibility of ganciclovir sodium
and total parenteral nutrient solution during simulated Y-site injection. Am J
Hosp Pharm. 1991 Jul;48(7):1538-9. PubMed PMID: 1909095.

7: Visor GC, Lin LH, Jackson SE, Winterle JS, Lee G, Kenley RA. Stability of
ganciclovir sodium (DHPG sodium) in 5% dextrose or 0.9% sodium chloride
injections. Am J Hosp Pharm. 1986 Nov;43(11):2810-2. PubMed PMID: 3492139.